Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Caraco Pharmaceutical Lab (OTC BB:CARA.OB)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | SEC | Insider
Location
1150 Elijah McCoy Drive
Detroit, MI 48202
Phone: (313) 871-8400
Fax: (313) 871-8314
Email: caracoinfo@caraco.com
Employees (last reported count): 58
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Biotechnology & Drugs
Company Website
 ·Home Page

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 88%
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Caraco Pharmaceutical Laboratories, Ltd. is engaged in the business of developing, manufacturing and marketing generic drugs for the ethical (prescription) and non-prescription or over-the-counter markets. Caraco's product portfolio includes 13 products in 20 strengths in 34 package sizes. Of these 13 products, four have been temporarily discontinued until the Company successfully completes the next Food and Drug Administration (FDA) inspection. The Company has submitted nine Abbreviated New Drug Applications (ANDAs) to the FDA for approval. During 2000, the dedicated development laboratory of Sun Pharmaceutical Industries Ltd. in Bombay was actively working on multiple ANDA submissions in connection with its agreement with the Company. Sun Pharma has facilitated the transfer of technology to Caraco with respect to 10 products. Including the transfer of technology by Sun Pharma, the Company has 21 products in various stages of active development.
More from Market Guide: Expanded Business Description

Financial Summary
CARA engages in the business of developing, manufacturing and marketing generic drugs for ethical and over-the-counter markets. For the three months ended 3/31/01, net sales increased 21% to $943 thousand. Net loss increased 1% to $1.7 million. Revenues reflect increased production and new drug development. Net loss reflects increased S/G/A expenses due to costs incurred for FDA compliance and the retention of an FDA consulting firm.

Recent Earnings Announcement
For the 3 months ended 06/30/2001, revenues were 925; after tax earnings were -1,953. (Preliminary; reported in thousands of dollars.)

More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Pay

Dilip Shanghvi, 45
Chairman
--  
Narendra Borkar, 60
CEO
$130K
Jitendra Doshi, 50
Sr. VP, Commercial
--  
Robert Kurkiewicz, 50
Sr. VP, Technical
125K
Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc..
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- OTC BB:CARA.OBAs of 31-Aug-2001
Price and Volume
52-Week Low
on 16-Jan-2001
$0.203
Recent Price$0.68 
52-Week High
on 8-May-2001
$0.95 
Beta1.22 
Daily Volume (3-month avg)5,636 
Daily Volume (10-day avg)23.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y | max]
52-Week Change+36.0%
52-Week Change
relative to S&P500
+82.5%
Share-Related Items
Market Capitalization$14.4M
Shares Outstanding21.2M
Float2.50M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq*)-$0.94 
Earnings (ttm)-$0.37 
Earnings (mrq)-$0.09 
Sales (ttm)$0.14 
Cash (mrq*)$0.02 
Valuation Ratios
Price/BookN/A 
Price/EarningsN/A 
Price/Sales (ttm)4.91 
Income Statements
Sales (ttm)$2.89M
EBITDA (ttm*)-$5.46M
Income available to common (ttm)-$7.72M
Profitability
Profit MarginN/A 
Operating MarginN/A 
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter
(fully updated)
31-Mar-2001
Most recent quarter
(flash earnings)
30-June-2001
Management Effectiveness
Return on Assets (ttm)-80.10%
Return on EquityN/A 
Financial Strength
Current Ratio (mrq*)0.22 
Debt/EquityN/A 
Total Cash (mrq)$0 
Short Interest
Shares ShortN/A 
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001, except mrq*/ttm* items as of 31-Mar-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.